These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Characterization of EHop-016, novel small molecule inhibitor of Rac GTPase. Montalvo-Ortiz BL, Castillo-Pichardo L, Hernández E, Humphries-Bickley T, De la Mota-Peynado A, Cubano LA, Vlaar CP, Dharmawardhane S. J Biol Chem; 2012 Apr 13; 287(16):13228-38. PubMed ID: 22383527 [Abstract] [Full Text] [Related]
3. Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Gao Y, Dickerson JB, Guo F, Zheng J, Zheng Y. Proc Natl Acad Sci U S A; 2004 May 18; 101(20):7618-23. PubMed ID: 15128949 [Abstract] [Full Text] [Related]
4. Critical off-target effects of the widely used Rac1 inhibitors NSC23766 and EHT1864 in mouse platelets. Dütting S, Heidenreich J, Cherpokova D, Amin E, Zhang SC, Ahmadian MR, Brakebusch C, Nieswandt B. J Thromb Haemost; 2015 May 18; 13(5):827-38. PubMed ID: 25628054 [Abstract] [Full Text] [Related]
5. Rational design and applications of a Rac GTPase-specific small molecule inhibitor. Akbar H, Cancelas J, Williams DA, Zheng J, Zheng Y. Methods Enzymol; 2006 May 18; 406():554-65. PubMed ID: 16472687 [Abstract] [Full Text] [Related]
6. RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers. De P, Carlson JH, Jepperson T, Willis S, Leyland-Jones B, Dey N. Oncotarget; 2017 Jan 10; 8(2):3072-3103. PubMed ID: 27902969 [Abstract] [Full Text] [Related]
7. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis. Morrison Joly M, Williams MM, Hicks DJ, Jones B, Sanchez V, Young CD, Sarbassov DD, Muller WJ, Brantley-Sieders D, Cook RS. Breast Cancer Res; 2017 Jun 30; 19(1):74. PubMed ID: 28666462 [Abstract] [Full Text] [Related]
10. Rac1 silencing, NSC23766 and EHT1864 reduce growth and actin organization of bladder smooth muscle cells. Wang R, Yu Q, Wang X, Li B, Ciotkowska A, Rutz B, Wang Y, Stief CG, Hennenberg M. Life Sci; 2020 Nov 15; 261():118468. PubMed ID: 32961232 [Abstract] [Full Text] [Related]
11. Inactivation of Rac1 reduces Trastuzumab resistance in PTEN deficient and insulin-like growth factor I receptor overexpressing human breast cancer SKBR3 cells. Zhao Y, Wang Z, Jiang Y, Yang C. Cancer Lett; 2011 Dec 26; 313(1):54-63. PubMed ID: 21943825 [Abstract] [Full Text] [Related]
12. R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis. Guo Y, Kenney SR, Muller CY, Adams S, Rutledge T, Romero E, Murray-Krezan C, Prekeris R, Sklar LA, Hudson LG, Wandinger-Ness A. Mol Cancer Ther; 2015 Oct 26; 14(10):2215-27. PubMed ID: 26206334 [Abstract] [Full Text] [Related]
14. Rac1 and Rac3 isoform activation is involved in the invasive and metastatic phenotype of human breast cancer cells. Baugher PJ, Krishnamoorthy L, Price JE, Dharmawardhane SF. Breast Cancer Res; 2005 Oct 26; 7(6):R965-74. PubMed ID: 16280046 [Abstract] [Full Text] [Related]